EUVIMEDEUVIMED entdecken
Crossref

Prognostic significance of pretreatment clinical and laboratory features in patients with ovarian cancer receiving neoadjuvant chemotherapy

Serhat Sekmek, Dogan Bayram, Safa Can Efil, Gokhan Ucar, Mehmet Ali Nahit Sendur, Fahriye Tugba Kos

Oncology in Clinical Practice · 2025

DOI: 10.5603/ocp.100576 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology in Clinical Practice, 2025. Verfasst von Serhat Sekmek und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Sekmek, S., Bayram, D., Efil, S. C., Ucar, G., Sendur, M. A. N., & Kos, F. T. (2025). Prognostic significance of pretreatment clinical and laboratory features in patients with ovarian cancer receiving neoadjuvant chemotherapy. Oncology in Clinical Practice. https://doi.org/10.5603/ocp.100576

Vancouver

Sekmek S, Bayram D, Efil SC, Ucar G, Sendur MAN, Kos FT. Prognostic significance of pretreatment clinical and laboratory features in patients with ovarian cancer receiving neoadjuvant chemotherapy. Oncology in Clinical Practice. 2025. doi:10.5603/ocp.100576

BibTeX
@article{Sekmek2025,
  author = {Sekmek, Serhat and Bayram, Dogan and Efil, Safa Can and Ucar, Gokhan and Sendur, Mehmet Ali Nahit and Kos, Fahriye Tugba},
  title = {Prognostic significance of pretreatment clinical and laboratory features in patients with ovarian cancer receiving neoadjuvant chemotherapy},
  journal = {Oncology in Clinical Practice},
  year = {2025},
  doi = {10.5603/ocp.100576}
}
Kostenlos starten →